NANDRO 250 is indicated for Osteoporosis due to androgen deficiency in hypogonadal males. It will also cause the muscle cell to store more nitrogen than it releases so that a positive nitrogen balance is achieved. A positive nitrogen balance is synonymous with anabolism and assimilates a larger amount of protein than usual. The result is a positive nitrogen balance and the protein building effect that accompany it. Nandro 250 is a long acting compound, with the Decanoate ester providing this drug a slow release time of up to three weeks.
NANDRO 250 is approved for use for the following indications:
- As an anabolic steroid
- Treatment of certain cases of disseminated breast cancer in women
- Osteoporosis due to androgen deficiency in hypogonadal males